Even though there is research that reported that ERβ ligand was able to activate Akt to promote remyelination [50], several studies regarding cancer prevention or treatment demonstrated that activation of ERβ repressed the Akt/mTOR signaling pathway [17,18,19]. Here, AKT1 is linked to cancer.